SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-15-030158
Filing Date
2015-05-13
Accepted
2015-05-13 16:16:14
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v409474_10q.htm 10-Q 275256
2 EXHIBIT 31.1 v409474_ex31-1.htm EX-31.1 10847
3 EXHIBIT 31.2 v409474_ex31-2.htm EX-31.2 10694
4 EXHIBIT 32.1 v409474_ex32-1.htm EX-32.1 5138
5 EXHIBIT 32.2 v409474_ex32-2.htm EX-32.2 5042
  Complete submission text file 0001144204-15-030158.txt   3134595

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT prph-20150331.xml EX-101.INS 379437
7 XBRL TAXONOMY EXTENSION SCHEMA prph-20150331.xsd EX-101.SCH 35360
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE prph-20150331_cal.xml EX-101.CAL 27042
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE prph-20150331_def.xml EX-101.DEF 167089
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE prph-20150331_lab.xml EX-101.LAB 251045
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prph-20150331_pre.xml EX-101.PRE 196545
Mailing Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901
Business Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901 2153450919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21617 | Film No.: 15858635
SIC: 2834 Pharmaceutical Preparations